
|Articles|September 22, 2015
Shaji Kumar on Treatment-Related Adverse Events From Monoclonal Antibodies
Author(s)Shaji Kumar
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
Advertisement
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
The main adverse event that is seen is infusion reactions, Kumar says. These reactions are easily managed and, even so, usually go away on their own.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Oncologist Explains What the Rasonque Approval Means for Patients With Metastatic Pancreatic Cancer
2
FDA Approves Rasonque, First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer
3
Dolly Parton, 80, Dies Following a Brief Battle with Cancer
4
Prostate Cancer Patients Got the Same Result in Fewer Visits
5




